Back to Qube Research & Technologies Ltd

ALNY
8 quarters

Position history for Qube Research & Technologies Ltd's holdings in ALNYLAM PHARMACEUTICALS INC

Qube Research & Technologies Ltd holds 838,187 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $277.3M as of 2026-Q1. The position was increased (+8.2% shares). ALNY represents 0.3% of Qube Research & Technologies Ltd's portfolio.

Current Value

$277.3M

Current Shares

838,187

Total Value Change

+$277.3M

Total Shares Change

+838,187

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
838,187
+8.2%
$277.3M0.3%$318.65
40
2025-Q4
Decreased
774,676
-4.5%
$308M0.3%$397.25
0
2025-Q3
New
811,278
-
$369.9M0.4%$447.49
51
2025-Q2
Exited
0
-100.0%
$00.0%$322.83
0
2025-Q1
Decreased
330,347
-31.9%
$89.2M0.1%$268.46
0
2024-Q4
Increased
485,260
+218.9%
$114.2M0.1%$236.01
58
2024-Q3
New
152,162
-
$41.8M0.1%$274.91
40
2024-Q2
Exited
0
-100.0%
$00.0%$243.00
0

Other major holders of ALNY: FMR LLC, Capital World Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used